{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:50:26Z","timestamp":1780077026328,"version":"3.54.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"am","delay-in-days":210,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajem.2021.05.054","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:30:01Z","timestamp":1621899001000},"page":"58-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines"],"prefix":"10.1016","volume":"49","author":[{"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bridwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"08","key":"10.1016\/j.ajem.2021.05.054_bb0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ajem.2021.05.054_bb0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.ajem.2021.05.054_bb0015","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.054_bb0020","series-title":"WHO Coronavirus (COVID-19) Dashboard","year":"2021"},{"issue":"03","key":"10.1016\/j.ajem.2021.05.054_bb0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/a-1178-3551","article-title":"Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis","volume":"40","author":"Langer","year":"2020","journal-title":"Hamostaseologie"},{"issue":"07","key":"10.1016\/j.ajem.2021.05.054_bb0030","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.ajem.2021.05.054_bb0035","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","author":"Cines","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.054_bb0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.054_bb0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.054_bb0050","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.05.054_bb0055","author":"Centers for Disease Control and Prevention Advisory Committee on Immunization Practice (ACIP)"},{"key":"10.1016\/j.ajem.2021.05.054_bb0060","author":"American Society of Hematology"},{"key":"10.1016\/j.ajem.2021.05.054_bb0065","author":"J&J\/Janssen Update"},{"key":"10.1016\/j.ajem.2021.05.054_bb0070","article-title":"Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH","author":"Oldenburg","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.ajem.2021.05.054_bb0080","series-title":"Janssen COVID-19 Vaccine Emergency Use Authorization","author":"Food and Drug Administration","year":"2021"},{"key":"10.1016\/j.ajem.2021.05.054_bb0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.15585\/mmwr.mm7009e4","article-title":"The Advisory Committee on Immunization practices\u2019 interim recommendation for use of Janssen COVID-19 vaccine\u2014United States, February 2021","volume":"70","author":"Oliver","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"17","key":"10.1016\/j.ajem.2021.05.054_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.15585\/mmwr.mm7017e4","article-title":"Updated recommendations from the advisory committee on immunization practices for use of the Janssen (Johnson & Johnson) COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome among vaccine recipients \u2013 United States, April 2021","volume":"70","author":"MacNeil","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajem.2021.05.054_bb0100","author":"International Society on Thrombosis and Haemostasis"},{"key":"10.1016\/j.ajem.2021.05.054_bb0105","series-title":"Guidance Produced by the Expert Haematology Panel (EHP) Focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT)","year":"2021"},{"issue":"4","key":"10.1016\/j.ajem.2021.05.054_bb0110","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/jcm10040683","article-title":"Heparin-induced thrombocytopenia: a review of new concepts in pathogenesis, diagnosis, and management","volume":"10","author":"Marchetti","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajem.2021.05.054_bb0115","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccine","author":"Tiede","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ajem.2021.05.054_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17474086.2019.1636645","article-title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","volume":"12","author":"Warkentin","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.ajem.2021.05.054_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)","author":"Thaler","year":"2021","journal-title":"J Thromb Haemost"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721004381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721004381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:53:51Z","timestamp":1760025231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721004381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":23,"alternative-id":["S0735675721004381"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.05.054","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.05.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}